Related Experiment Video
Updated: Dec 13, 2025

08:34
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
10.6K
Implications of telomerase reverse transcriptase in tumor metastasis
Yongkang Zou1, Yu-Sheng Cong2, Junzhi Zhou2
1Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518107, China.
BMB Reports
|August 1, 2020
Summary
Telomerase reverse transcriptase (TERT) drives cancer metastasis through non-canonical functions beyond telomere maintenance. Understanding these roles is key to combating cancer spread and mortality.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Biology
Background:
- Metastasis is the primary cause of cancer-related deaths, yet the invasion-metastasis cascade is poorly understood.
- Telomerase is crucial for cancer progression by maintaining telomere homeostasis and genomic stability.
- Telomerase reverse transcriptase (TERT) has enzymatic and non-enzymatic functions vital for cancer biology.
Purpose of the Study:
- To review the mechanisms by which TERT facilitates tumor metastasis.
- To highlight the non-canonical functions of telomerase in cancer progression.
- To provide an update on TERT's role in the invasion-metastasis cascade.
Main Methods:
- Literature review of recent advances in cancer biology and telomerase research.
- Analysis of studies investigating TERT's functions independent of its enzymatic activity.
- Synthesis of evidence linking TERT to various stages of the invasion-metastasis cascade.
Main Results:
- TERT promotes key steps of the invasion-metastasis cascade, including proliferation, inflammation, EMT, angiogenesis, DNA repair, and gene expression.
- Non-canonical TERT functions significantly contribute to cancer cell survival and spread.
- TERT's multifaceted roles extend beyond telomere maintenance, impacting multiple hallmarks of cancer.
Conclusions:
- TERT plays a critical role in facilitating tumor metastasis through diverse non-canonical mechanisms.
- Targeting TERT's non-enzymatic functions may offer novel therapeutic strategies against cancer metastasis.
- Further research into TERT's complex roles is essential for developing effective anti-metastatic treatments.
Related Concept Videos
Replicative Cell Senescence
4.2K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K
Telomeres and Telomerase
26.4K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
26.4K
Telomeres and Telomerase
6.6K
6.6K
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K

